A double-blind placebo-controlled trial of risperidone in autistic disorder

被引：2
|
作者：
McDougle, C
Aman, MG
McCracken, JT
Scahill, L
Tierney, E
Vitiello, B
机构：
[1] Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA
[2] Ohio State Univ, Nisonger Ctr, Columbus, OH 43210 USA
[3] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA
[4] Yale Univ, Sch Nursing, New Haven, CT 06536 USA
[5] Yale Univ, Sch Med, New Haven, CT 06536 USA
[6] Johns Hopkins Univ, Sch Med, New Haven, CT USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2003年 / 13卷
关键词：
D O I：
10.1016/S0924-977X(03)92062-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S327 / S328
页数：2
相关论文
共 50 条
  • [31] A Double-Blind Placebo Controlled Trial of Ginkgo biloba Added to Risperidone in Patients with Autistic Disorders
    Hasanzadeh, Elmira
    Mohammadi, Mohammad-Reza
    Ghanizadeh, Ahmad
    Rezazadeh, Shams-Ali
    Tabrizi, Mina
    Rezaei, Farzin
    Akhondzadeh, Shahin
    CHILD PSYCHIATRY & HUMAN DEVELOPMENT, 2012, 43 (05) : 674 - 682
  • [32] A Double-Blind Placebo Controlled Trial of Ginkgo biloba Added to Risperidone in Patients with Autistic Disorders
    Elmira Hasanzadeh
    Mohammad-Reza Mohammadi
    Ahmad Ghanizadeh
    Shams-Ali Rezazadeh
    Mina Tabrizi
    Farzin Rezaei
    Shahin Akhondzadeh
    Child Psychiatry & Human Development, 2012, 43 : 674 - 682
  • [33] Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial
    Muller, Jacqueline E.
    Wentzel, Ignatius
    Koen, Liezl
    Niehaus, Dana J. H.
    Seedat, Soraya
    Stein, Dan J.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (01) : 43 - 48
  • [34] The cult of the double-blind placebo-controlled trial
    Ellis, SJ
    Adams, RF
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1997, 51 (01): : 36 - 39
  • [35] Clozapine augmented with risperidone in the treatment of schizophrenia: A randomized, double-blind, placebo-controlled trial
    Josiassen, RC
    Joseph, A
    Kohegyi, E
    Stokes, S
    Dadvand, M
    Paing, WW
    Shaughnessy, RA
    AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (01): : 130 - 136
  • [36] Risperidone augmentation for schizophrenia partially responsive to clozapine: A double-blind, placebo-controlled trial
    Freudenreich, Oliver
    Henderson, David C.
    Walsh, Jared P.
    Culhane, Melissa A.
    Goff, Donald C.
    SCHIZOPHRENIA RESEARCH, 2007, 92 (1-3) : 90 - 94
  • [37] Augmentation with risperidone in chronic resistant depression: A double-blind placebo-controlled maintenance trial
    Nemeroff, CB
    Gharabawi, GM
    Canuso, CM
    Mahmoud, R
    Loescher, A
    Turkoz, I
    Rapaport, MH
    Gharabawi, GM
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S159 - S159
  • [38] Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder
    King, BH
    Wright, DM
    Handen, BL
    Sikich, I
    Zimmerman, AW
    McMahon, W
    Cantwell, E
    Davanzo, PA
    Dourish, CT
    Dykens, EM
    Hooper, SR
    Jaselskis, CA
    Leventhal, BL
    Levitt, J
    Lord, C
    Lubetsky, MJ
    Myers, SM
    Ozonoff, S
    Shah, BG
    Snape, M
    Shernoff, EW
    Williamson, K
    Cook, EH
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2001, 40 (06): : 658 - 665
  • [39] Tetrahydrobiopterin in the treatment of children with autistic disorder - A double-blind placebo-controlled crossover study
    Danfors, T
    von Knorring, AL
    Hartvig, P
    Langstrom, B
    Moulder, R
    Stromberg, B
    Torstenson, R
    Wester, U
    Watanabe, Y
    Eeg-Olofsson, O
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (05) : 485 - 489
  • [40] A clinical trial of adjunctive cyproheptadine in the treatment of autistic disorder: a double-blind and placebo controlled trial
    Akhondzadeh, S
    Mohammadi, MR
    Erfani, S
    Tehranidoost, M
    Amini, H
    Kashani, L
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (05) : 670 - 670
12345